D.W. Cescon

机构：Princess Margaret Cancer Centre

发表论文 4 篇 · 总被引 12 次 · h-index 2

代表论文

• LBA2 Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC): Additional safety analysis from TROPION-Breast01 (2024 · ESMO Open · 被引 9)
• LBA22 Patient-reported outcomes (PROs) with sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in patients (pts) with previously untreated PD-L1+ metastatic triple-negative breast cancer (mTNBC) in the phase III ASCENT-04/KEYNOTE-D19 study (2025 · Annals of Oncology · 被引 3)
• Toronto workshop on late recurrence in estrogen receptor-positive breast cancer: Part 1: Late Recurrence: Current understanding, clinical considerations (2021 · UNC Libraries)
• Toronto workshop on late recurrence in Estrogen receptor-positive breast cancer: Part 2: Approaches to predict and identify late recurrence, research directions (2021 · UNC Libraries)